Posts

Showing posts with the label CAR T Cell Therapy Market

Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

CAR T Cell Therapy Market Overview, Analysis, Impact of Coronavirus (COVID-19) Pandemic

Image
  CAR T Cell Therapy Market CAR T-cell treatment with chimeric antigen receptors (CAR) is a method of obtaining immune cells known as T cells. CAR T-cell therapy is used to treat lymphomas, leukemias, and multiple myeloma, among other diseases. Many clinical trials for CAR T-cell treatments have been done around the world in order to expand the therapy options for cancer. In 2010, the National Cancer Institute's research team published the first study on CAR T-cell therapy, a new type of cancer treatment. Increasing approvals for Car T cell therapy products is estimated to drive the global Car T cell therapy market growth during the forecast period. As people become more aware of this novel way of treating cancer, demand for auto T cell therapy products rises. As a result, the industry's major players are working on new items, which is propelling the market forward. For example, the US Food and Drug Administration authorised Yescarta, a cell-based gene therapy, in October 20...

CAR- T Cell Therapy Market Overview, Drivers and Impact of Coronavirus (COVID-19) Pandemic

Image
CAR T-cell treatment with chimeric antigen receptors (CAR) is a method of obtaining immune cells known as T cells. CAR T-cell therapy is used to treat lymphomas, leukemias, and multiple myeloma, among other diseases. Many clinical trials for CAR T-cell treatments have been done around the world in order to expand the therapy options for cancer. In 2010, the National Cancer Institute's research team published the first study on CAR T-cell therapy, a new type of cancer treatment. Global Car T Cell Therapy Market – Impact of Coronavirus (COVID-19) Pandemic As a result of the COVID–19 outbreak and a reduction of global research effort, many firms around the world have seen their operations and financial performance deteriorate. The closing of academic and scientific institutes, as well as testing facilities, has had a significant detrimental impact. As a result, the CAR-T cell therapy market trials have been pushed back. CAR-T Cell Therapy Market COVID-19 is a serious hazard to ...

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027